Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Sell · Filed 04/30

Trade details

Type
Insider sale
Amount
$53,513.1
Shares · price
3,214 sh · $16.65 a share
Held after
120,399 sh
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Trade date
26/04/30
Filed
26/04/30
Days to filing
0 days

Sold 2.6% of holdings

Share of holding sold
2.6%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 03/31~05/30

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Sell10b5-1 planNurix Therapeutics

    $107.9K

    Filed 06/25

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $104.1K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $79.5K

    Filed 01/30